Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
Nvidia has been the big artificial intelligence (AI) winner so far, but these two companies might have better long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback